Literature DB >> 7127226

Uterine cancers in Alberta: trends of incidence and mortality.

H S King, D T Wigle, G B Hill, J Silins.   

Abstract

Death certificates were reviewed for the 543 Alberta women who died during the period 1969 through 1978 and for whom the underlying cause of death was coded as uterine cancer. To evaluate the recorded cause of death Alberta Cancer Registry records, which existed for 97% of the women, were examined. Calculations from the revised information showed an increase in the mortality of cancer of the corpus uteri and a decrease in the mortality of cancer of the cervix uteri over the 10-year period, but neither was statistically significant. During the same period in Alberta the incidence of cancer of the corpus uteri increased significantly and the incidence of cancer of the cervix uteri decreased significantly.

Entities:  

Mesh:

Year:  1982        PMID: 7127226      PMCID: PMC1862165     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  10 in total

1.  Estrogen and endometrial carcinoma. An independent pathology review supporting original risk estimate.

Authors:  J Gordon; J W Reagan; W D Finkle; H K Ziel
Journal:  N Engl J Med       Date:  1977-09-15       Impact factor: 91.245

2.  Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix.

Authors:  A B Miller; J Lindsay; G B Hill
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

3.  Clinical and pathological features and survival of endometrial cancer patients in relation to prior use of estrogens.

Authors:  J M Elwood; D A Boyes
Journal:  Gynecol Oncol       Date:  1980-10       Impact factor: 5.482

4.  Recent trends in the incidence and mortality of cancer of the uterine corpus in Connecticut.

Authors:  L D Marrett; J M Elwood; S M Epid; J W Meigs; J T Flannery
Journal:  Gynecol Oncol       Date:  1978-04       Impact factor: 5.482

5.  The effect of hysterectomies and screening on mortality from cancer of the uterus in Canada.

Authors:  A B Miller; T Visentin; G R Howe
Journal:  Int J Cancer       Date:  1981-05-15       Impact factor: 7.396

6.  Estrogens and endometrial cancer: some answers and some further questions.

Authors:  J M Elwood
Journal:  Can Med Assoc J       Date:  1981-05-01       Impact factor: 8.262

7.  Association of exogenous estrogen and endometrial carcinoma.

Authors:  D C Smith; R Prentice; D J Thompson; W L Herrmann
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245

8.  Risk of exogenous estrogen therapy and endometrial cancer.

Authors:  F R Jelovsek; C B Hammond; B H Woodard; R Draffin; K L Lee; W T Creasman; R T Parker
Journal:  Am J Obstet Gynecol       Date:  1980-05-01       Impact factor: 8.661

9.  The changing trends of uterine cancer and cytology: a study of morbidity and mortality trends over a twenty year period.

Authors:  K Kim; R D Rigal; J R Patrick; J K Walters; A Bennett; W Nordin; J R Claybrook; R R Parekh
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

10.  Oestrogen use and survival in endometrial cancer.

Authors:  J Collins; A Donner; L H Allen; O Adams
Journal:  Lancet       Date:  1980-11-01       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.